Company Release no. 05/2017
To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 16 March, 2017
Notice to Convene Annual General Meeting 2017
The board of directors of Veloxis Pharmaceuticals A/S, CVR no. 26 52 77 67 ("the Company"), hereby convenes the annual general meeting in the Company which will be held on
Friday 7 April 2017 at 9 am. CET
at the offices of Plesner Advokatpartnerselskab, Amerika Plads 37, 2100 Copenhagen, Denmark.
Agenda
1 Report by the Company's board of directors on the Company's activities during the past financial year
2 Presentation of the audited annual report for approval
3 Resolution on covering of losses as per the approved annual report
4 Election of members to the board of directors
5 Election of auditor
6 Approval of fee to the board of directors for the financial year 2017
7 Proposal by the board of directors on authorization to the board of directors to issue warrants and amendment of the articles of association in accordance therewith
8 Proposal by the board of directors that all documents prepared for use by a general meeting of the Company at or after the general meeting, including the notice and the minutes, shall be prepared in English only and amendment of the articles of association in accordance therewith
9 Proposal by the board of directors on authorization to the Company to acquire own shares
10 Proposal by the board of directors on authorization to the chairman of the annual general meeting, with a right of substitution, to file the resolutions passed at the general meeting for registration with the Danish Business Authority
Please see attached document for complete proposals.
